Price T Rowe Associates Inc. MD Has $193,000 Position in SelectQuote, Inc. (NYSE:SLQT)

Price T Rowe Associates Inc. MD boosted its position in SelectQuote, Inc. (NYSE:SLQT) by 16.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,819 shares of the company’s stock after purchasing an additional 7,322 shares during the period. Price T Rowe Associates Inc. MD’s holdings in SelectQuote were worth $193,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of SLQT. OneDigital Investment Advisors LLC acquired a new stake in shares of SelectQuote in the fourth quarter valued at about $46,000. Cibc World Markets Corp acquired a new stake in shares of SelectQuote in the fourth quarter valued at about $47,000. Oppenheimer & Co. Inc. acquired a new stake in SelectQuote during the fourth quarter worth approximately $47,000. Raymond James Financial Inc. bought a new stake in SelectQuote in the fourth quarter worth approximately $97,000. Finally, MetLife Investment Management LLC increased its holdings in SelectQuote by 84.8% in the fourth quarter. MetLife Investment Management LLC now owns 80,248 shares of the company’s stock worth $299,000 after purchasing an additional 36,815 shares in the last quarter. Institutional investors and hedge funds own 34.59% of the company’s stock.

SelectQuote Trading Down 1.1%

NYSE SLQT opened at $2.30 on Friday. The company has a market cap of $395.07 million, a price-to-earnings ratio of -25.50 and a beta of 1.26. The company has a quick ratio of 6.36, a current ratio of 6.36 and a debt-to-equity ratio of 2.10. SelectQuote, Inc. has a 52 week low of $1.62 and a 52 week high of $6.86. The business has a 50 day moving average price of $3.17 and a 200-day moving average price of $3.50.

SelectQuote (NYSE:SLQT) last announced its earnings results on Monday, May 12th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The company had revenue of $408.16 million for the quarter, compared to analysts’ expectations of $412.83 million. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. As a group, equities analysts expect that SelectQuote, Inc. will post -0.07 earnings per share for the current fiscal year.

Insider Activity at SelectQuote

In related news, insider Sarah Taylor Anderson sold 50,000 shares of SelectQuote stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $5.44, for a total transaction of $272,000.00. Following the transaction, the insider now owns 1,166 shares of the company’s stock, valued at $6,343.04. The trade was a 97.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.40% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Separately, Noble Financial upgraded SelectQuote to a “strong-buy” rating in a report on Wednesday, February 12th.

SelectQuote Company Profile

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.